Grangeot-Keros L, Pustowoit B, Hobman T
Department of Microbiology and Immunology, Hôpital Antoine Béclère, Clamart, France.
J Clin Microbiol. 1995 Sep;33(9):2392-4. doi: 10.1128/jcm.33.9.2392-2394.1995.
Cobas Core Rubella IgG EIA recomb (Roche), a new, commercially available rubella enzyme immunoassay using recombinant rubella-like particles, was compared with a hemagglutination inhibition assay (Rubenosticon; Organon Teknika) and two whole-virus enzyme immunoassays (IMx [Abbott] and Platelia [Sanofi Diagnostics Pasteur]). Compared with those of these reference assays, the relative sensitivities of Cobas Core Rubella IgG recomb were 100, 94, and 95.9%, with specificities amounting to 80.8, 98, and 98.2%, respectively.
Cobas Core风疹IgG重组酶免疫测定法(罗氏公司)是一种新型的、可商购的使用重组风疹样颗粒的风疹酶免疫测定法,将其与血凝抑制试验(Rubenosticon;欧加农公司)以及两种全病毒酶免疫测定法(IMx [雅培公司]和Platelia [赛诺菲诊断公司巴斯德分部])进行了比较。与这些参比测定法相比,Cobas Core风疹IgG重组酶免疫测定法的相对灵敏度分别为100%、94%和95.9%,特异性分别为80.8%、98%和98.2%。